# ProShares Trust II: overview

AGQ · NYSE · CIK 1415311 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agq.md) · [Financials](/companies/agq/financials.md) · [Filings](/companies/agq/filings.md) · [Insiders](/companies/agq/insiders.md)

Latest reported revenue: [$49.7m](/filings/0001193125-26-340159.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-340159).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [31.0](/filings/0001193125-26-214433.md) | [31.6](/filings/0001193125-26-340159.md) | not reported | not reported | [44.6](/filings/0001193125-26-214433.md) | [49.7](/filings/0001193125-26-340159.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | [1381.4%](/filings/0001193125-26-214433.md) | [541.5%](/filings/0001193125-26-340159.md) | not reported | not reported | [1071.6%](/filings/0001193125-26-214433.md) | [(2420.3%)](/filings/0001193125-26-340159.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/agq/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $93.6m | 3,758,900 | Call | Added +33,200 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $68.9m | 1,013,400 | Call | Reduced −374,900 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $63.7m | 2,560,302 |  | Added +2,559,300 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $61.2m | 2,232,100 | Call | New +2,232,100 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $49.9m | 2,006,300 | Put | Added +352,900 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $45.3m | 1,293,800 | Call | New +1,293,800 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $41.9m | 616,200 | Call | Reduced −69,500 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $41.6m | 611,400 | Put | Reduced −301,500 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $39.1m | 1,186,700 | Call | Added +305,000 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $34.9m | 513,300 | Call | Reduced −279,000 |

## Recent filings

[All 714 filings](/companies/agq/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 15:46 ET | [10-Q](/filings/0001193125-26-340159.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340159 |
| 2026-05-12 | 15:27 ET | [8-K](/filings/0001193125-26-219236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-219236 |
| 2026-05-08 | 15:21 ET | [10-Q](/filings/0001193125-26-214433.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214433 |
| 2026-02-26 | 17:25 ET | [10-K](/filings/0001193125-26-077441.md) | Annual report, period 2025-12-31 | 0001193125-26-077441 |
| 2026-02-12 | 18:03 ET | [8-K](/filings/0001193125-26-046988.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-046988 |
| 2025-11-07 | 15:15 ET | [10-Q](/filings/0001193125-25-272134.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272134 |
| 2025-11-04 | 16:47 ET | [8-K](/filings/0001193125-25-264886.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-264886 |
| 2025-08-08 | 15:24 ET | [10-Q](/filings/0001193125-25-176892.md) | Quarterly report, period 2025-06-30 | 0001193125-25-176892 |
| 2025-06-06 | 16:44 ET | [8-K/A](/filings/0001193125-25-137140.md) | 9.01 Financial statements and exhibits | 0001193125-25-137140 |
| 2025-05-29 | 16:37 ET | [8-K](/filings/0001193125-25-130703.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-130703 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-077441.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7b9477f8-0a26-4c92-bded-25aace85a98d)

## About the filer

- CIK: 1415311
- Tickers: AGQ, BOIL, EUO, GLL, KOLD, SCO, SVXY, UCO, UGL, ULE, UVXY, VIXM, VIXY, YCL, YCS, ZSL
- Exchange: NYSE
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.